All Peter Gwynne articles
-
NewsBiomarkers may someday help clinicians better detect Borrelia burgdorferi infections
Current tests for Lyme disease often miss infections during the early critical window and cannot tell whether bacteria are still present or were cleared years ago. New research suggests that anti-lipid antibodies may address these shortcomings.
-
NewsResearchers investigate the underlying causes of post-treatment Lyme disease syndrome
With an estimated one million Americans afflicted with post-treatment Lyme disease syndrome, newly funded research seeks to determine whether the condition is triggered by a persistent autoimmune response, and if a test can be devised to pinpoint who is more likely to develop it.
-
News‘Subway map’ of Lyme disease pathways IDs potential treatment targets
Researchers have developed a genome-scale metabolic model of key metabolic activities of the bacterium that causes Lyme disease, successfully identifying two compounds that selectively target routes only used by Lyme disease to infect a host.